病例精选:IVUS指导下NSTEMI左主干闭塞病变优化PCI一例

2019-05-07 李辉 赵婕 王恒东 中国医学论坛报今日循环

张某,男,56岁因阵发性胸闷、胸痛4年,持续胸痛5小时急诊入院。

一、病例简介:

张某,男,56岁因阵发性胸闷、胸痛4年,持续胸痛5小时急诊入院。

病人4年前反复出现胸闷、胸痛,常于活动后或饱食后加重,每次持续3-5分钟左右,休息或含服硝酸甘油后可缓解。曾行CTA检查是前降支狭窄75%,未规律服药。

入院前五小时胸痛再发,程度较前明显加重,放散至后背部,无濒死感,无大汗,无头晕,无明显呼吸困难,含服硝酸甘油症状不缓解。

危险因素:高血压病史6余年,最高血压160/100mmHg,糖尿病4年,高脂血症,吸烟20年,每日20支。

查体:BP:150/90mmHg,双肺呼吸音清,无罗音。心率:72次/分,节律齐,各瓣膜听诊区杂音,双下肢不肿。

二、辅助检查:

实验室检查:

CK-MB:45U/L; CK:387U/L; AST:56U/L   

TnI:0.3ng/mL;Myo:513ng/mL

WBC :10.6×109/L;HB:144g/L

BUN: 4.82mmol/L;CRE:86μmol/L

GLU:12.6mmol/L; TG:3.82mmol/L;

CH:5.76mmol/L; LDL—C:2.99mmol/L.

Echo: 

左室壁节段性运动异常 二尖瓣及主动脉瓣少量返流。LV:54mm,LVEF:58%

心电图:

胸痛发作时的心电图                                        



胸痛缓解时的心电图



三、临床诊断

1.冠心病

      急性非ST段抬高型心肌梗死

      心功能Ⅰ级 (killip分级)

2.2级高血压

3.2型糖尿病

4.高脂血症

四、病例分析及处理:

病人入院后根据临床特点诊断为NSTEMI,立即启动胸痛中心NSTEMI治疗流程,首先给予药物治疗,拜阿司匹林 300mg  口服,替格瑞洛180mg  口服,阿托伐他汀钙 40mg 口服,琥珀酸美托洛尔47.5mg  日一次口服,苯磺酸氨氯地平 5mg 日一次 口服,硝酸异山梨酯10mg 日三次 口服,低分子肝素钠(克赛)0.4ml 日二次  皮下注射。

缺血评分Grace评分为:117分(中高危)。治疗策略为给予充分的双抗及抗凝治疗,观察病情变化,若病人病情进一步加重可给予24小时内急诊PCI治疗。患者入院后17小时后仍然胸痛胸闷症状不缓解,建议家属患者应行介入治疗,家属同意行PCI治疗。

冠脉造影(静态片)





冠脉造影提示:

LM:起始部100%闭塞,LAD和LCX可经侧支循环显影,管腔尚可。RCA全程散在斑块,近段第一转折处80%管状狭窄,远段第二转折后90%局限性狭窄。

危险分层:

 SYNTAX score:31

 GRACE score:117,High risk.

 CRUSADE score :29, low risk ,

 Bleeding probability:5.5%。

五、治疗策略:

1. 病人长期心绞痛发作,既往CTA示有严重狭窄,平时可能建立了侧支循环,有缺血预适应。此次为急性非ST段抬高型心肌梗死。病人血流动力学稳定,无明显心衰症状。

2. 冠脉造影显示LM起始部100%闭塞,RCA给予左冠脉系统提供良好的侧支循环,此次若行PCI治疗应为有保护的左主干介入治疗,相对安全系数较高。

3. 若行急诊PCI治疗应在IABP支持下进行较安全。择期再行RCA介入治疗。

4.若行急诊PCI治疗,开通LM后应在IVUS指导下选择左主干+分叉病变应行单支架亦或是双支架技术。

六、手术经过:

首先植入IABP,  指引导管6F EBU3.5 ,指引导丝:FieldXT-A,SION,RunthroughNS;微导管Finecross;球囊Maverick 2.5×15mm,扩张(12atm×10s),恢复前向血流,应用IVUS检查,结果示:





PCI过程

根据IVUS检查结果,LAD近中段,LCX中段和LM均需植入支架。LCX开口面积较大(MLA:6.73mm2),斑块负荷轻,LM及分叉病变应用单支架Crossover技术。NaNo2.75×33mm支架植入LCX中、远段,Quantum NC balloon 3.0×15mm ,后扩张(18atm×10s)。

LAD近、中段植入NaNo3.0×36mm。LM-pLAD植入NaNo3.5×15mm (16atm× 10s)。

LAD先行Quantum NC balloon3.0×12mm和3.5×12mm20atm后扩张。 

LM :QuantumNC balloon 4.0×12mm 22atm(POT) .Rewireinto LCX。

最后行IVUS检查(LM-LAD and LM-LCX ),支架膨胀和贴壁良好。











最后造影结果





七、总 结:

1.对于急性非ST段抬高型心肌梗死,虽然Grace评分不是极高危病人,如果患者病情无明显好转,应该积极地进行冠脉造影,及时行PCI治疗,可以预防病情的进一步恶化,挽救濒死心肌,改善心功能,避免心源性猝死。

2. 左主干病变介入治疗,及时应用IABP支持可以提高手术的成功率,同时可以改善心肌缺血和心功能。

3. 应用IVUS指导左主干和分叉病变可以更好地观察血管直径、斑块病变情况、钙化斑块的程度、分叉开口部斑块负荷程度,从而选择单支架技术或双支架技术。应用IVUS可以更好地观察支架膨胀和贴壁情况,减少并发症。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1977586, encodeId=7b6b19e75863a, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Tue Jan 07 13:22:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718537, encodeId=2d871e1853711, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Sep 01 15:22:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482250, encodeId=6d6d14822501a, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500930, encodeId=a7dd15009304d, content=<a href='/topic/show?id=3cad13104d5' target=_blank style='color:#2F92EE;'>#NSTEMI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13104, encryptionId=3cad13104d5, topicName=NSTEMI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597175, encodeId=9fd3159e175c9, content=<a href='/topic/show?id=931f9e189f6' target=_blank style='color:#2F92EE;'>#闭塞病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97189, encryptionId=931f9e189f6, topicName=闭塞病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d32d18505898, createdName=zhlpower, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
    2020-01-07 drj2003
  2. [GetPortalCommentsPageByObjectIdResponse(id=1977586, encodeId=7b6b19e75863a, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Tue Jan 07 13:22:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718537, encodeId=2d871e1853711, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Sep 01 15:22:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482250, encodeId=6d6d14822501a, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500930, encodeId=a7dd15009304d, content=<a href='/topic/show?id=3cad13104d5' target=_blank style='color:#2F92EE;'>#NSTEMI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13104, encryptionId=3cad13104d5, topicName=NSTEMI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597175, encodeId=9fd3159e175c9, content=<a href='/topic/show?id=931f9e189f6' target=_blank style='color:#2F92EE;'>#闭塞病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97189, encryptionId=931f9e189f6, topicName=闭塞病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d32d18505898, createdName=zhlpower, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1977586, encodeId=7b6b19e75863a, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Tue Jan 07 13:22:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718537, encodeId=2d871e1853711, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Sep 01 15:22:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482250, encodeId=6d6d14822501a, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500930, encodeId=a7dd15009304d, content=<a href='/topic/show?id=3cad13104d5' target=_blank style='color:#2F92EE;'>#NSTEMI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13104, encryptionId=3cad13104d5, topicName=NSTEMI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597175, encodeId=9fd3159e175c9, content=<a href='/topic/show?id=931f9e189f6' target=_blank style='color:#2F92EE;'>#闭塞病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97189, encryptionId=931f9e189f6, topicName=闭塞病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d32d18505898, createdName=zhlpower, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1977586, encodeId=7b6b19e75863a, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Tue Jan 07 13:22:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718537, encodeId=2d871e1853711, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Sep 01 15:22:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482250, encodeId=6d6d14822501a, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500930, encodeId=a7dd15009304d, content=<a href='/topic/show?id=3cad13104d5' target=_blank style='color:#2F92EE;'>#NSTEMI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13104, encryptionId=3cad13104d5, topicName=NSTEMI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597175, encodeId=9fd3159e175c9, content=<a href='/topic/show?id=931f9e189f6' target=_blank style='color:#2F92EE;'>#闭塞病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97189, encryptionId=931f9e189f6, topicName=闭塞病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d32d18505898, createdName=zhlpower, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
    2019-05-09 hb2008ye
  5. [GetPortalCommentsPageByObjectIdResponse(id=1977586, encodeId=7b6b19e75863a, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Tue Jan 07 13:22:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718537, encodeId=2d871e1853711, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Sep 01 15:22:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482250, encodeId=6d6d14822501a, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500930, encodeId=a7dd15009304d, content=<a href='/topic/show?id=3cad13104d5' target=_blank style='color:#2F92EE;'>#NSTEMI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13104, encryptionId=3cad13104d5, topicName=NSTEMI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597175, encodeId=9fd3159e175c9, content=<a href='/topic/show?id=931f9e189f6' target=_blank style='color:#2F92EE;'>#闭塞病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97189, encryptionId=931f9e189f6, topicName=闭塞病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d32d18505898, createdName=zhlpower, createdTime=Thu May 09 00:22:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]

相关资讯

Lancet:PCI三种指导方式谁更优秀?(OCT、IVUS与血管造影)

经皮冠状动脉介入治疗(PCI)经常在血管造影的指导下进行。血管内超声(IVUS)已被证明可减少PCI术后的主要不良心血管事件(MACE)。光学相干断层成像(OCT)的分辨率高于IVUS,虽然一些研究结果表明,它可能会导致支架植入后的小管腔直径。我们试图评估基于OCT的支架选型策略在最小支架面积方面,是否相似或优于IVUS,以及优于血管造影。在这项随机对照试验中,我们招募了18岁或以上的患者。符合条

病例:AMI血栓自溶后IVUS

  第三届临床心血管病大会暨第九届中国冠心病介入沙龙(CISC)于2月9日—12日在北京九华山庄召开。沈阳军区总医院马颖艳在会上与大家分享了一例急性心肌梗死(AMI)严重血栓病变自溶后血管内超声(IVUS)的病例。   一般资料   66岁男患者,因“突发心前区疼痛7小时”入院。   冠心病危险因素:吸烟,糖尿病(DM)。   心电图:V1—V5 Q波,ST段上移0.1—0.4m

IVUS指导下直接PCI救治高危急性心肌梗死一例

患者,男性,48岁。因突发胸痛3小时来诊。查体:血压120/70mmHg,神志清楚,双肺呼吸音清,无罗音,心率76次/分,律齐,无杂音,双下肢无水肿。急诊心电图示V1-V4导联ST段弓背向上型抬高。诊断为:急性前壁心肌梗死,符合直接PCI手术指征,积极准备后行急诊冠状动脉造影术。造影显示(图1A-C):LM无狭窄,LAD开口起完全闭塞,LCX、OM、RCA存在不同程度动脉粥样硬化性狭窄,血流TIM

病例分享:IVUS精准指导支架再狭窄治疗一例

随着腔内影像学(IVUS,OCT等)和功能学(FFR,iFR)的发展,我们可以在腔内影像学或功能学的指导下,优化PCI治疗,使治疗更趋于精准化,使靶病变能够选择应用最佳的治疗和尽可能改善预后的精准医疗,从而提高患者的生活质量和减少再次手术的病痛。针对该病例IVUS提供既往支架信息,判断支架内再狭窄可能原因及病变位置,更趋于精准化,从而指导本次手术策略,更大程度上优化PCI治疗,使患者获益最大化。

钱菊英:IVUS和FFR: 指导老年女性患者介入治疗的更佳策略

4月11日上午9点20分,在广州举办的中国南方国际心血管病学术会议的女性心血管病论坛上,来自上海复旦大学附属中山医院的钱菊英教授向我们详细阐述了IVUS和FFR在老年女性患者介入治疗的指导作用。 钱教授首先向我们介绍了女性CHD患者的临床特点。自1980年以来,男性CHD患者的死亡率下降,而女性CHD患者的死亡率反而升高。随着年龄的增加,女性患CHD的风险相对更高。对于心绞痛的病

冠状动脉钙化病变的介入治疗

冠状动脉钙化是指钙质在冠状动脉管壁组织或粥样硬化斑块内沉积,X线透视呈高密度影像。冠心病患者尸检时发现80%的冠状动脉病变有不同程度钙化,但冠状动脉造影时仅有约15%~60%的病变合并钙化。血管内超声(IVUS)检出率较高,可发现60%~70% 的病变合并钙化。冠状动脉钙化的机理尚不完全清楚,可能与以下因素有关:(1)冠状动脉粥样硬化严重程度和范围:粥样硬化越严重、范围越广泛,钙化程度往